Sophie D. Morse

Oncology
77 Brant Ave Ste 200
Clark, NJ 07066

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 04, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026